TY - JOUR T1 - Tackling risk factors for type 2 diabetes in adolescents: PRE-STARt study in Euskadi JO - Anales de Pediatría (English Edition) T2 - AU - Alustiza,Elena AU - Perales,Amaia AU - Mateo-Abad,Maider AU - Ozcoidi,Irene AU - Aizpuru,Garbiñe AU - Albaina,Olatz AU - Vergara,Itziar SN - 23412879 M3 - 10.1016/j.anpede.2020.11.005 DO - 10.1016/j.anpede.2020.11.005 UR - https://www.analesdepediatria.org/en-tackling-risk-factors-for-type-articulo-S2341287921001332 AB - IntroductionObesity in the child population and its effect in the development of metabolic diseases are a public health issue. One of the aims of the European Project in a health system, is the evaluation of the effectiveness of a multidisciplinary health promotion program directed at adolescents with risk factors associated with the development of type 2 Diabetes Mellitus (T2DM). Patients and methodsRandomised clinical trial with two groups of 12–14 year-old overweight adolescents. The intervention group took part in a multidisciplinary program for 24 months. This program was based on 11 group sessions (8 main sessions and 3 additional support ones) for adolescents and their guardians. The control group received usual care at primary care level. Longitudinal regression models were adjusted to assess the evolution of anthropometric measures and living habits at baseline, 3, 6, 12, and 24 months in both groups. ResultsThere were 92 participants, equally distributed by group. Statistically significant differences were observed between intervention and control groups in several results: evolution of the body mass index; increase in the consumption of fruits and vegetables; decrease in the consumption of snacks and sweetened drinks; and increase in the number of days per week with more than one hour of physical activity. ConclusionsThe results confirm the effectiveness of this multidisciplinary program, both in the evolution of the body mass index, and in the improvement of the eating and physical activity habits, all of them risk factors for the future development of metabolic diseases, such as T2DM. ER -